InvestorsHub Logo

vinmantoo

06/08/22 2:42 PM

#8221 RE: maximumgriff #8220

I don’t use dumb terms like that, but will go higher than where it’s sits now. Easy answer



Correct answer. Final approval will given another bump but it is ludicrous to think NVAX will approach its previous high of over $300. That happened when there were no vaccines and the whole market was up for grabs. A bigger boost for NVAX will only come as more sales data is generated. Keep in mind that mRNA has an bivalent booster that includes an omicron specific vaccination.